Delivery Order SPE2DB24D2106-SPE2DB24FAUXS

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $1,104.48, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that runs through December 31, 2025. The IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including both common and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the supply of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA) Medical Supply Chain division. The single-award indefinite delivery contract (IDC) has a ceiling value of $5,534.45 and runs through July 1, 2024. This order is part of a larger $499,999,999 IDC held by DMS Pharmaceutical Group, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,010.95 firm fixed-price contract is for the supply of 4,566,851,320 tablets of the prescription drug Ondansetron Hydrochloride 4 mg. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award, valued at $21,409.49, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4565095622 - Ondansetron ODT 4 mg Tablet 30s. This award is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, which allows the DLA to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,399.77 firm fixed-price delivery order is for the supply of 4,564,618,079 units of Ondansetron HCL 4 MG Tablet 500S to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,835.84 firm fixed-price delivery order is for the supply of 4,565,044,224 units of the drug ondansetron hydrochloride. The delivery order is being fulfilled under a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.65 order is for 500 units of the prescription medication Ondansetron HCL 4 mg tablet. The award is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 held by DMS Pharmaceutical Group with DLA, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,045.09 contract is for the delivery of 4,566,450,193 units of Ondansetron HCL 4 mg tablets by November 18, 2024. The award is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,021.90, is for the delivery of 4,565,078,614 Ondansetron HCL 4 MG tablets in packages of 500. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,587.62 contract is for the delivery of Ondansetron ODT 8 mg tablets. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical supply...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB24FAUXS
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order worth $14,027.16 for the supply of 4 mg ondansetron hydrochloride tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, under an indefinite delivery contract (IDC) valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

Generated 12/13/24, 9:15 AM